Oxford Respiratory Trials Unit (ORTU)
 |
About ORTU
The Oxford Respiratory Trials Unit (ORTU) is a Clinical Trials Unit which specialises in the design, delivery, analysis and administration of trials across the broad scope of Respiratory Medicine and Respiratory Diseases.
We run national and international trials related to our academic areas of interest, as well as supporting trials led by other teams and industry. Our scope of work includes clinical trials at all phases, including translational studies, phase II discovery studies and multicentre definitive randomised trials.
We partner with a broad range of academic funders (National Institute of Health Research, Medical Research Council, British Lung Foundation, National Cancer Research Institute, CRUK) and partners in industry. Key funding for ORTU is derived from the NIHR Research Delivery Network (RDN) and the Oxford NIHR Biomedical Research Centre.
ORTU publications
-
Impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a Markov state-transition model - A UK weight and wellness cancer landscape analysis.
Journal article
Dong J. et al, (2025), Cancer Epidemiol, 97
-
Pneumothorax: An update on clinical spectrum, diagnosis and management
Journal article
Iqbal B. et al, (2025), Clinical Medicine, 25, 100327 - 100327
-
Retrospective analysis of the sensitivity of reporting of thoracic computed tomography for pleural malignancy: an Australian multi-centre study
Journal article
Graffen SC. et al, (2025), Journal of Thoracic Disease, 17, 1958 - 1966
-
Taking a fresh approach to education inThorax
Journal article
Thompson E. et al, (2025), Thorax
-
Estimating the disease burden of respiratory syncytial virus (RSV) in older adults in England during the 2023/24 season: a new national hospital-based surveillance system
Preprint
Symes R. et al, (2025)
-
Glucocorticoid treatment and new‐onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: A systematic review and meta‐analysis
Journal article
Golubic R. et al, (2025), Diabetic Medicine, 42
-
ERS Congress 2024: highlights from the Thoracic Oncology Assembly.
Journal article
Pereira Catarata MJ. et al, (2025), ERJ open research, 11, 1171 - 2024
-
Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis Against Multidrug-Resistant Bacteria.
Journal article
Abdulqawi R. et al, (2025), Transplant infectious disease : an official journal of the Transplantation Society